Actinium Pharmaceuticals (NYSE:ATNM) Earns “Buy” Rating from HC Wainwright
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $4.00 price objective on the stock. HC Wainwright’s target price would indicate a potential upside of 247.83% from the company’s current price. […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $4.00 price objective on the stock. HC Wainwright’s target price would indicate a potential upside of 247.83% from the company’s current price. […]
